Medwave Pharmaceuticals Private Limited
About Medwave Pharmaceuticals Private Limited
Data last updated:
Medwave Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 05 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51103DL2015PTC279787. Its GSTIN is 07AAJCM7289H1ZW (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Hooda and Preeti.
Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at House No. 1 Block B Hari Enclave Kirari, Delhi, India – 110041.
As per the financials filed for FY 2020, the company reported a revenue of ₹6.64 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹6.41 Lakh (net margin -96.5%) and EBITDA of -₹6.39 Lakh (EBITDA margin -96.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medwave Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 1 Block B Hari Enclave Kirari, Delhi, India – 110041
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Medwave Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medwave Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medwave Pharmaceuticals Private Limited, buy the company report.
Financials of Medwave Pharmaceuticals Private Limited
FY 2020 filings availableMedwave Pharmaceuticals Private Limited reported revenue of ₹6.64 Lakh (up 36% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 36% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -96.2% | ||||
| Net Profit Margin | -96.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medwave Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medwave Pharmaceuticals Private Limited
Medwave Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Hooda | Director | 15 Jun 2016 | 10 Years 4 Months | Current |
| Preeti | Director | 19 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Medwave Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sabiscon Pharmaceuticals Private Limited | ₹6.66 Lakh (FY 2025) | 2.0% | Surat, Gujarat, India | |||
| Tacaso Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2025) | 202.0% | Salem, Tamil Nadu, India | |||
| Zeltron Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2021) | -78.0% | Ahmedabad, Gujarat, India | |||
| Devank Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2024) | -31.0% | Gautam Buddh Nagar, Uttar Pradesh, India | |||
| Medwave Pharmaceuticals Private Limitedthis company | ₹6.64 Lakh (FY 2020) | -₹6.41 Lakh | -96.5% | 36.0% | Delhi, India | |
| Ratantray Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2025) | 12.0% | Jaipur, Rajasthan, India | |||
| Venterra Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2016) | 0.0% | Pune, Maharashtra, India |
To see the full peer comparison of Medwave Pharmaceuticals Private Limited, buy the company report.
Auditor
Medwave Pharmaceuticals Private Limited is audited by DEEPAK BANSAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK BANSAL | FY 2017 | 535012 |
Shareholding
The shareholding of Medwave Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medwave Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medwave Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medwave Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medwave Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM7289H1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medwave Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medwave Pharmaceuticals Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Preeti ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Medwave Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 05 May 2015 (11+ years old) and is registered under CIN U51103DL2015PTC279787.
Medwave Pharmaceuticals has 2 current directors:
- Ajay Hooda - Director
- Preeti - Director
The latest financial statements of Medwave Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Medwave Pharmaceuticals is 07AAJCM7289H1ZW, registered in Delhi.
The CIN (Corporate Identification Number) of Medwave Pharmaceuticals is U51103DL2015PTC279787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medwave Pharmaceuticals was incorporated on 05 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medwave Pharmaceuticals by revenue are Sabiscon Pharmaceuticals Private Limited, Tacaso Pharmaceuticals Private Limited, Zeltron Pharmaceuticals Private Limited, Devank Pharmaceuticals Private Limited, Ratantray Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Preeti ceased to be Additional Director on 29 Sep 2018. Lalit Chaudhary ceased to be Director on 21 Feb 2018. Preeti was appointed as Director on 19 Feb 2018. Medwave Pharmaceuticals has 7 board changes on record in total.
The registered office of Medwave Pharmaceuticals is at House No. 1 Block B Hari Enclave Kirari, Delhi, India – 110041.
Medwave Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Medwave Pharmaceuticals is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
